198 related articles for article (PubMed ID: 34638301)
1. Impact of KMT2A Rearrangement and CSPG4 Expression in Pediatric Acute Myeloid Leukemia.
Hoffmeister LM; Orhan E; Walter C; Niktoreh N; Hanenberg H; von Neuhoff N; Reinhardt D; Schneider M
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638301
[No Abstract] [Full Text] [Related]
2. Mutational landscape and clinical outcome of pediatric acute myeloid leukemia with 11q23/KMT2A rearrangements.
Yuen KY; Liu Y; Zhou YZ; Wang Y; Zhou DH; Fang JP; Xu LH
Cancer Med; 2023 Jan; 12(2):1418-1430. PubMed ID: 35833755
[TBL] [Abstract][Full Text] [Related]
3. High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial.
Shiba N; Ohki K; Kobayashi T; Hara Y; Yamato G; Tanoshima R; Ichikawa H; Tomizawa D; Park MJ; Shimada A; Sotomatsu M; Arakawa H; Horibe K; Adachi S; Taga T; Tawa A; Hayashi Y
Br J Haematol; 2016 Feb; 172(4):581-91. PubMed ID: 26684393
[TBL] [Abstract][Full Text] [Related]
4. Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.
Assaf N; El-Cheikh J; Bazarbachi A; Salem Z; Farra C; Chakhachiro Z; Nassif S; Zaatari G; Mahfouz R
Mol Biol Rep; 2019 Apr; 46(2):2003-2011. PubMed ID: 30701458
[TBL] [Abstract][Full Text] [Related]
5. Molecular Characterization of Pediatric Acute Myeloid Leukemia: Results of a Multicentric Study in Brazil.
Andrade FG; Noronha EP; Brisson GD; Dos Santos Vicente Bueno F; Cezar IS; Terra-Granado E; Thuler LCS; Pombo-de-Oliveira MS;
Arch Med Res; 2016 Nov; 47(8):656-667. PubMed ID: 28476193
[TBL] [Abstract][Full Text] [Related]
6. Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/
Bill M; Mrózek K; Kohlschmidt J; Eisfeld AK; Walker CJ; Nicolet D; Papaioannou D; Blachly JS; Orwick S; Carroll AJ; Kolitz JE; Powell BL; Stone RM; de la Chapelle A; Byrd JC; Bloomfield CD
Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26340-26346. PubMed ID: 33020282
[TBL] [Abstract][Full Text] [Related]
7. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.
Hollink IH; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Pratcorona M; Abbas S; Kuipers JE; van Galen JF; Beverloo HB; Sonneveld E; Kaspers GJ; Trka J; Baruchel A; Zimmermann M; Creutzig U; Reinhardt D; Pieters R; Valk PJ; Zwaan CM
Blood; 2011 Sep; 118(13):3645-56. PubMed ID: 21813447
[TBL] [Abstract][Full Text] [Related]
8. Profiling of somatic mutations and fusion genes in acute myeloid leukemia patients with FLT3-ITD or FLT3-TKD mutation at diagnosis reveals distinct evolutionary patterns.
Guan W; Zhou L; Li Y; Yang E; Liu Y; Lv N; Fu L; Ding Y; Wang N; Fang N; Liu Q; Wang B; Li F; Zhang J; Wang M; Wang L; Jing Y; Li Y; Yu L
Exp Hematol Oncol; 2021 Apr; 10(1):27. PubMed ID: 33836835
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive immunophenotypic study of acute myeloid leukemia with KMT2A (MLL) rearrangement in adults: A single-institution experience.
Konoplev S; Wang X; Tang G; Li S; Wang W; Xu J; Pierce SA; Jia F; Jorgensen JL; Ravandi F; Issa GC; Medeiros LJ; Wang SA
Cytometry B Clin Cytom; 2022 Mar; 102(2):123-133. PubMed ID: 34964255
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplantation for pediatric acute myeloid leukemia patients with KMT2A rearrangement; A nationwide retrospective analysis in Japan.
Miyamura T; Kudo K; Tabuchi K; Ishida H; Tomizawa D; Adachi S; Goto H; Yoshida N; Inoue M; Koh K; Sasahara Y; Fujita N; Kakuda H; Noguchi M; Hiwatari M; Hashii Y; Kato K; Atsuta Y; Okamoto Y
Leuk Res; 2019 Dec; 87():106263. PubMed ID: 31707119
[TBL] [Abstract][Full Text] [Related]
11. Patients aged less than 3 years with acute myeloid leukaemia characterize a molecularly and clinically distinct subgroup.
Hara Y; Shiba N; Yamato G; Ohki K; Tabuchi K; Sotomatsu M; Tomizawa D; Kinoshita A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
Br J Haematol; 2020 Feb; 188(4):528-539. PubMed ID: 31612466
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.
Green CL; Koo KK; Hills RK; Burnett AK; Linch DC; Gale RE
J Clin Oncol; 2010 Jun; 28(16):2739-47. PubMed ID: 20439648
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemia.
Vetro C; Haferlach T; Meggendorfer M; Stengel A; Jeromin S; Kern W; Haferlach C
Cancer Genet; 2020 Jan; 240():15-22. PubMed ID: 31698332
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukemia with t(10;11)(p11-12;q23.3): Results of Russian Pediatric AML registration study.
Zerkalenkova E; Lebedeva S; Kazakova A; Tsaur G; Starichkova Y; Timofeeva N; Soldatkina O; Aprelova E; Popov A; Ponomareva N; Baidun L; Meyer C; Novichkova G; Maschan M; Maschan A; Marschalek R; Olshanskaya Y
Int J Lab Hematol; 2019 Apr; 41(2):287-292. PubMed ID: 30624859
[TBL] [Abstract][Full Text] [Related]
15. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
[TBL] [Abstract][Full Text] [Related]
16. CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia.
Zhang Y; Wang F; Chen X; Zhang Y; Wang M; Liu H; Cao P; Ma X; Wang T; Zhang J; Zhang X; Lu P; Liu H
Cancer; 2018 Aug; 124(16):3329-3338. PubMed ID: 29932212
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetics and associated mutation profile in patients with acute monocytic leukemia.
Xing S; Wang B; Gao Y; Li M; Wang T; Sun Y; Shen Y; Chao H
Int J Lab Hematol; 2019 Aug; 41(4):485-492. PubMed ID: 31099482
[TBL] [Abstract][Full Text] [Related]
18. Myeloid sarcoma is associated with poor clinical outcome in pediatric patients with acute myeloid leukemia.
Xu LH; Wang Y; Chen ZY; Fang JP
J Cancer Res Clin Oncol; 2020 Apr; 146(4):1011-1020. PubMed ID: 31919567
[TBL] [Abstract][Full Text] [Related]
19. Analysis of class I and II aberrations in Iraqi childhood acute myeloid leukemia using filter paper cards.
Al-Kzayer LF; Uyen le TN; Al-Jadiry MF; Al-Hadad SA; Al-Badri SA; Ghali HH; Ameen NA; Liu T; Matsuda K; Abdulkadhim JM; Al-Shujairi TA; Matti ZI; Hasan JG; Al-Abdullah HM; Al-Ani MH; Saber PA; Khalil HM; Inoshita T; Kamata M; Koike K; Sakashita K
Ann Hematol; 2014 Jun; 93(6):949-55. PubMed ID: 24464319
[TBL] [Abstract][Full Text] [Related]
20. Fusion partner-specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML.
Matsuo H; Yoshida K; Nakatani K; Harata Y; Higashitani M; Ito Y; Kamikubo Y; Shiozawa Y; Shiraishi Y; Chiba K; Tanaka H; Okada A; Nannya Y; Takeda J; Ueno H; Kiyokawa N; Tomizawa D; Taga T; Tawa A; Miyano S; Meggendorfer M; Haferlach C; Ogawa S; Adachi S
Blood Adv; 2020 Oct; 4(19):4623-4631. PubMed ID: 32991719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]